Market Tracker

07/31 6:05pm ET

Exelixis Inc (NASDAQ:EXEL)

During the Trading Day
4.03 -0.24 / -5.62%
Data as of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
4.03 0.00 / 0.00%
 
Volume: 79.3K

Today’s Trading

Previous close4.27
Today’s open4.22
Day’s range4.00 - 4.22
Volume5,030,346
Average volume (3 months)3,962,649
Market cap$831.3M
Dividend yield--
Data as of 3:59pm ET, 07/31/2014

Growth & Valuation

Earnings growth (last year)-44.57%
Earnings growth (this year)-17.74%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-33.96%
P/E ratioNM
Price/Sales36.00
Price/Book11.90

Competitors

 Today’s
change
Today’s
% change
NXTMNxStage Medical Inc-0.38-2.77%
SGMOSangamo BioSciences ...-0.65-5.19%
LXRXLexicon Pharmaceutic...-0.07-4.55%
BRLIBio-Reference Labora...-0.54-1.69%
Data as of 3:59pm ET, 07/31/2014

Financials

Next reporting dateAugust 1, 2014
EPS forecast (this quarter)-$0.38
Annual revenue (last year)$31.3M
Annual profit (last year)-$244.8M
Net profit margin-781.03%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Michael M. Morrissey
Chief Financial Officer, VP &
Controller
Deborah Burke
Corporate headquarters
South San Francisco, California

Forecasts